A Two-Part, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenous CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 30 Jul 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

10 Apr 2018 According to a Cara Therapeutics media release, data will be presented at the 2018 Spring Clinical Meetings of the National Kidney Foundation.
15 Mar 2018 According to a Cara Therapeutics media release, the company presented clinical data from the phase IIb part of this trial at the American Society of Nephrology's Annual Meeting (in Nov 2017).
17 Jan 2018 Status changed from recruiting to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com